Caribou Biosciences (CRBU) Other Working Capital Changes (2020 - 2026)
Caribou Biosciences (CRBU) reported Other Working Capital Changes of -$522000.0 for Q1 2026, down 98.48% year-over-year from -$34.3 million in Q1 2025, and down 143.76% on a QoQ basis from $1.2 million in Q4 2025.
Caribou Biosciences (CRBU) has 7 years of Other Working Capital Changes data on file, last reported at -$522000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 98.48% year-over-year to -$522000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$807000.0 (down 778.15% YoY) and the FY2025 annual result came in at -$548000.0, down 226.56% from the prior year.
- Other Working Capital Changes declined to -$522000.0 in Q1 2026 per CRBU's latest filing, from $1.2 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $5.6 million in Q2 2023 and bottomed at -$16.1 million in Q4 2023.
- The 5-year median for Other Working Capital Changes is -$161000.0 (2022), against an average of -$1.0 million.
- Peak annual rise in Other Working Capital Changes reached 3549.69% in 2023, while the deepest fall reached 1433.94% in 2023.
- Tracing CRBU's Other Working Capital Changes over 5 years: stood at -$1.0 million in 2022, then plunged by 1433.94% to -$16.1 million in 2023, then soared by 105.59% to $900000.0 in 2024, then jumped by 32.56% to $1.2 million in 2025, then slumped by 143.76% to -$522000.0 in 2026.
- Per Business Quant, the three latest CRBU Other Working Capital Changes figures stand at -$522000.0 (Q1 2026), $1.2 million (Q4 2025), and $155000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -522,000.00 |
| Mar 31, 2026 | -522,000.00 |
| Dec 31, 2025 | 1.19 Mn |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | 155,000.00 |
| Sep 30, 2025 | 155,000.00 |
| Jun 30, 2025 | -1.63 Mn |
| Jun 30, 2025 | -1.63 Mn |
| Mar 31, 2025 | -263,000.00 |
| Mar 31, 2025 | -263,000.00 |
| Dec 31, 2024 | 900,000.00 |
| Dec 31, 2024 | 900,000.00 |
| Sep 30, 2024 | -149,000.00 |
| Sep 30, 2024 | -149,000.00 |
| Jun 30, 2024 | -369,000.00 |
| Jun 30, 2024 | -369,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Dec 31, 2023 | -16.09 Mn |
| Dec 31, 2023 | -16.09 Mn |
| Sep 30, 2023 | -6.08 Mn |
| Sep 30, 2023 | -6.08 Mn |
| Jun 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 5.55 Mn |
| Mar 31, 2023 | -323,000.00 |
| Mar 31, 2023 | -323,000.00 |
| Dec 31, 2022 | -1.05 Mn |
| Dec 31, 2022 | -1.05 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | -161,000.00 |
| Jun 30, 2022 | -161,000.00 |
| Mar 31, 2022 | 487,000.00 |
| Mar 31, 2022 | 487,000.00 |
| Dec 31, 2021 | -30.67 Mn |
| Dec 31, 2021 | -30.67 Mn |
| Sep 30, 2021 | 30.67 Mn |
| Sep 30, 2021 | 30.67 Mn |
| Dec 31, 2020 | 57,000.00 |
| Dec 31, 2020 | 57,000.00 |
| Sep 30, 2020 | 57,000.00 |
| Sep 30, 2020 | 57,000.00 |